CIK 0001851484 · <br>Emerging growth company
CITIUS ONCOLOGY, INC.
Sign in to watch- Ticker
- CTOR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 994362660
- Phone
- (908) 967-6677
- Business address
- 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
- Former names
- TenX Keane Acquisition
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Shareholder vote results
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Executive or director change
- 424B3 Offering Prospectus
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 424B3 Offering Prospectus
- 8-K Event Other events
Page 1 of 14 · 268 filings